Navigation Links
Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
Date:2/26/2008

the company's website at http://www.pharmacopeia.com.

Pharmacopeia Contact:

Brian M. Posner

Executive Vice President and Chief Financial Officer

Pharmacopeia

609-452-3643

This press release, and oral statements made with respect to information contained in this press release, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those which express plan, anticipation, intent, goal, contingency or future development and/or otherwise are not statements of historical fact. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. These forward- looking statements include, but are not limited to, statements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its DARA program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS178990, a product candidate from its SARM program, Pharmacopeia's Phase 1 clinical studies with respect to PS178990, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS031291, a product candidate from its chemokine receptor CCR1 program, Pharmacopeia's estimates of the market opportunities for its product candidates, including PS433540, PS178990 and PS031291, Pharmacopeia's ability to successfully perform under its collaborations with Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Schering-Plough and Wyeth, Pharmacopeia's ability to build its pipeline of novel drug candidates through its own internally-funded drug discover
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
8. Pharmacopeia to Present at BIO CEO & Investor Conference 2008
9. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:9/29/2014)... (PRWEB) September 30, 2014 Top10BestSEOHosting.com ... and reviews about hosting products. It is headed ... rich experience. The site offers research-based information and ... and suppliers in the current market. , ... and announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... September 29, 2014 Each year over ... to complaints of dizziness and imbalance. Symptoms of vestibular ... next and the population range can vary as much ... people will be seeking medical assistance for dizziness and ... from combat with post blast or post concussion injuries ...
(Date:9/29/2014)... Thousand Oaks, Calif. (PRWEB) September 29, 2014 ... and Injury Relief (PMIR) and Thousand Oaks Surgery Center ... Serra Medical Plaza, a state-of-the-art healthcare facility in Thousand ... to these two practices that offer Conejo Valley residents ... patients with acute and chronic pain, while TOSC physicians ...
(Date:9/29/2014)... The specialists from LunaDress always prides themselves on their ... of the price. To benefit more ladies, LunaDress often ... its online store. Today, the company has happily launched ... party dresses . The company’s sales manager says that ... , "We are excited to announce the new ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 3Health News:At The Beginning Of Autumn, LunaDress Provides Huge Deals On Its Cocktail Party Dresses 2
... Thought-Leader Joins Senior Management Team, NASHVILLE, Tenn., ... of revenue cycle management and clinical communication,solutions, announced ... Senior,Vice President of Corporate Strategy, effective immediately., ... the business of healthcare,and health information technology. Most ...
... 20 Shamir Optical,Industry Ltd. (Nasdaq: SHMR ) ... on Wednesday, May 28, 2008, and has scheduled a,conference ... that morning., The conference call will be broadcast ... to http://www.kcsa.com approximately ten minutes before the,conference ...
... to be widely available for chronic pain sufferers., ... Pharma, Inc.,(Other OTC:INNP.PK - News) is pleased to ... to the Natural Pain Relief Center,non-narcotic proprietary breakthrough ... one in five Americans suffer with chronic pain ...
... to treat patients with latent tuberculosis (TB), who are infected ... less than half the time and at a lower cost ... a multi-center, randomized controlled trial. The results will be presented ... on Tuesday, May 20. , We found that using ...
... 20 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that Gilles ... Finance at the Montreal Sheraton Centre on ... Busines$ Meets Finance, Busines$ Meets Finance ...
... Health IT Solutions Recognized, BOSTON, May 20 ... TEPR Awards honorees during the Opening Session of,the ... Conference in,Ft. Lauderdale, Florida., TEPR Awards annually ... and solutions. The 2008 TEPR Awards honorees,are:, ...
Cached Medicine News:Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results 2Health News:Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment 2Health News:Rifampin: Latent TB treatment saves time money and lives 2Health News:Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre 2Health News:2008 TEPR Awards Honorees Announced 2
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: